5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The France Contraceptive Devices Market is segmented by Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Device (IUD), and Other Types) and Gender.
2018 - 2026
The France contraceptive devices market size is estimated to expand at a CAGR of around 8.07% over the forecast period. Rising awareness in french population regarding contraception methods, investments by key players to develop innovative devices, and favorable government initiatives to improve access to products are the major factors accelerating the growth.
In addition, rising the prevalence of sexually transmitted diseases and growing need for population control fueling the regional market growth. For instance, as per the data published by Institute for Health Metrics and Evaluation, there were 9.27 million french population were living with HIV/AIDS & sexually transmitted diaseses in year 2019. Thus, increasing demand for contraceptive devices to avoid additional healthcare costs is likely to aid market growth.
Moreover, initiatives by governments to raise awareness regarding contraceptives and family planning have also helped the growth of the market. However, the side effects of contraceptive devices have been restraining the studied market's growth.
As per the scope of the report, contraceptives devices have been barriers that attempt to prevent pregnancy by physically preventing sperm from entering the uterus. Contraception is more commonly known as fertility, and birth control is described as the method used to avoid pregnancy. They include male condoms, female condoms, cervical caps, diaphragms, and contraceptive sponges with spermicide.
In the report, a detailed analysis of the France contraceptive devices market is provided. The market studied is evaluated by type and gender.
Report scope can be customized per your requirements. Click here.
A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also to a lesser extent protect against genital herpes, human papillomavirus (HPV), and syphilis.
In France, the use of condoms has significantly increased in adolescents due to easy availability and convenience. According to the survey conducted by l’information et la prévention du sida, in 2019, about 53% of studied population of 15-24 years old said they used a condom the everytime when they had sex. Thus, effective protection from sexually transmitted infections and high demand from the young population to enhance their sexual experience is expected to aid the product demand.
To understand key trends, Download Sample Report
The market is moderately competitive in nature. Some of the key industry contributors are AbbVie Inc. (Allergan), Bayer Healthcare, Cooper Surgical Inc. and Mylan Laboratories among others. Companies are undertaking strategic initiatives such as increasing investment in R&D of innovative products to gain a competitive edge from generic products available in the market.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Awareness about Sexually Transmitted Diseases (STDs)
4.2.2 Rising Rate of Unintended Pregnancies & Rise in Government Initiatives
4.3 Market Restraints
4.3.1 Side Effects Associated with the Use of Contraceptive Devices
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.3 Cervical Caps
5.1.5 Vaginal Rings
5.1.6 Intra Uterine Device (IUD)
5.1.7 Other Types
5.2 By Gender
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AbbVie Inc. (Allergan)
6.1.2 Bayer Healthcare
6.1.3 Cooper Surgical Inc.
6.1.4 Mylan Laboratories
6.1.5 Pfizer Inc.
6.1.6 Teva Pharmaceutical Industries Ltd
6.1.7 DKT International
6.1.8 Pregna International Limited
6.1.9 Reckitt Benckiser
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments